EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Naloxone can alter experimental pain and mood in humans



Naloxone can alter experimental pain and mood in humans



Physiological Psychology 9(3): 245-250



The possibility was studied that endogenous opioids attenuate aversive experience in humans. Two experimental pain procedures, cold pressor pain, and ischemic pain produced by the submaximal effort tourniquet technique, were administered on each of 2 consecutive experimental days. Seven subjects received double-blind infusions of the opiate antagonist naloxone on day 1 and saline on day 2; for 7 other subjects, the order was reversed. Based on earlier studies of exogenous opiate analgesics, the present experiment was designed to maximize subject anxiety and the disturbingness of the ischemic pain. Under these conditions, opiate receptor blockade significantly affected ratings and tolerance times for ischemic pain, anxiety and mood. These results contrast with those of recent studies in which naloxone effects on experimental pain in humans were subtle or indiscernible, and suggest that psychological factors will have to be controlled and studied in the investigation of physiological bases of pain and other psychological states.

(PDF emailed within 0-6 h: $19.90)

Accession: 005956273

Download citation: RISBibTeXText

DOI: 10.3758/BF03326970



Related references

Endorphins: naloxone fails to alter experimental pain or mood in humans. Science 199(4333): 1093-1095, 1978

Opiate receptor blockade can alter experimental pain and mood in humans. Federation Proceedings 40(3 PART 1): 306, 1981

Naloxone does not alter the perception of pain induced by electrical and thermal stimulation of the skin in healthy humans. Pain 34(3): 271-276, 1988

Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and rats. Journal of Hepatology 5(2): 149-153, 1987

Naloxone does not antagonize the psychomotor and mood effects of nitrous oxide in humans. Anesthesiology (Hagerstown) 81(3A): A224, 1994

The effects of naloxone on nitrous oxide-induced analgesia, mood, and psychomotor impairment in humans. Anesthesia & Analgesia 80(2 SUPPL ): S376, 1995

Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature 306(5940): 264-265, 1983

Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects. Proceedings of the National Academy of Sciences of the United States of America 74(3): 1291-1294, 1977

Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis?. Molecular Pain 4(): 58-58, 2008

Effects of mood on pain responses and pain tolerance: an experimental study in chronic back pain patients. Pain 138(2): 392-401, 2008

Naloxone reversal of morphine analgesia but failure to alter reactivity to pain in the formalin test. Life Sciences 22(4): 295-302, 1978

Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: effects of naloxone. Pain 19(1): 13-25, 1984

Naloxone does not affect pain sensitivity, mood or cognition in patients with high levels of beta-endorphin in plasma. Life Sciences 30(21): 1827-1834, 1982

Effect of fentanyl and naloxone on thalamically induced pain in humans. Society for Neuroscience Abstracts 21(1-3): 1171, 1995